Related Experiment Videos
[Screening programs for sporadic colorectal carcinoma]
12. interní oddĕlení a subkatedra gastroenterologie, prednosta prim. MUDr. M. Zavoral, Ph.D., Ustrední vojenská nemocnice, Praha.
Vnitrni Lekarstvi
|July 23, 2002
Summary
Colorectal cancer (CRC) screening, particularly fecal occult blood testing (FOBT) followed by colonoscopy, significantly reduces mortality. Early detection through regular screening is crucial for combating this prevalent disease.
Area of Science:
- Oncology
- Gastroenterology
- Public Health
Context:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally, with the Czech Republic having the highest incidence.
- Sporadic CRC accounts for approximately 75% of cases, primarily affecting individuals over 50 years old with no family history.
- Age over 50 is a significant risk factor, with CRC incidence doubling each decade.
Purpose:
- To review available screening methods for sporadic colorectal cancer in asymptomatic individuals over 50.
- To highlight the efficacy of fecal occult blood testing (FOBT) and subsequent colonoscopy in reducing CRC mortality.
- To emphasize the importance of national screening programs for early detection and prevention.
Summary:
- Available screening options include FOBT, flexible sigmoidoscopy, combined procedures, colonoscopy, and virtual colonography.
- FOBT is widely used for asymptomatic individuals over 50, with colonoscopy recommended for FOBT-positive cases.
- Prospective studies demonstrate a 15-33% decrease in CRC mortality with FOBT-based screening programs.
Impact:
- National CRC screening programs, implemented in Germany (1977) and the Czech Republic (2000), aim to reduce disease burden.
- Screening is essential to combat high CRC mortality rates, making it a public health imperative.
- Early detection through screening can significantly improve patient outcomes and survival rates.